Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

tDCS-Augmented Exposure Therapy for Pathological Fear

NCT03095482 is registered in ClinicalTrials.gov with University of Texas at Austin as lead sponsor.

NCT NCT03095482
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03095482 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
tDCS-Augmented Exposure Therapy for Pathological Fear
Lead sponsor
University of Texas at Austin
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2017
Completion date
September 6, 2018
Enrollment
49 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

specific phobias